Vaccine Panel to Review Claim of Covid Vaccine Link to Children's Deaths: Impact on Pfizer and Moderna Stocks
Pfizer and Moderna stocks experienced a decline following a report suggesting that Trump administration health officials are linking Covid vaccines to the deaths of 25 children. The report indicates that this claim will be presented to a key vaccine panel advising the CDC next week. This panel plays a crucial role in vaccine access decisions, reviewing immunization data and making recommendations on eligibility and insurance coverage.
The Department of Health and Human Services has not yet responded to the report. Pfizer's stock dropped over 3% and Moderna's shares fell more than 7% in response to the news. Novavax, known for its protein-based Covid shots, also saw a decline of more than 4%. Health and Human Services Secretary Robert F. Kennedy Jr. is making changes to vaccine policy, including dropping Covid shot recommendations for healthy kids and pregnant women and setting new limits on new jab approvals.
Studies have shown that mRNA technology-based vaccines, such as those from Pfizer and Moderna, are safe and effective, with serious side effects being extremely rare. Moderna emphasized that its vaccine's safety is closely monitored by various regulatory bodies across multiple countries, with no new safety concerns identified in children or pregnant women. Pfizer has not yet commented on the report.
The claim linking Covid vaccines to children's deaths is reportedly based on information submitted to the Vaccine Adverse Event Reporting System, which monitors vaccine safety. This system collects unverified reports of side effects from various sources. Only through thorough investigation can scientists and public health officials determine if a vaccine contributed to reported side effects.